TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026)
TherapeuticsMD's Non-Current Assets came in at $21.41 million for Q2 2026, down 14.5% from $25.04 million a year earlier and down 4.1% from the prior quarter.
TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD's Non-Current Assets was $23.21 million, down 12.6% from FY2024.
- Non-Current Assets has declined in each of the last six years, with a five-year compound annual growth rate of -15.3% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $26.56 million in FY2024 (-15.7%), $31.51 million in FY2023 (-10.2%), $35.11 million in FY2022 (-29.8%) and $50 million in FY2021 (-6.0%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q2 2018.
- Year-over-year, Non-Current Assets has declined for 24 consecutive quarters, with an average decline of 14.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Assets ranged from 6.0% (Q4 2021) to 29.8% (Q4 2022).
- Business Quant data shows TXMD's Non-Current Assets at $22.32 million (Q1 2026), $23.21 million (Q4 2025) and $24.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 21.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.41 Mn |
| Mar 31, 2026 | 22.32 Mn |
| Dec 31, 2025 | 23.21 Mn |
| Sep 30, 2025 | 24.17 Mn |
| Jun 30, 2025 | 25.04 Mn |
| Mar 31, 2025 | 25.72 Mn |
| Dec 31, 2024 | 26.56 Mn |
| Sep 30, 2024 | 27.40 Mn |
| Jun 30, 2024 | 28.30 Mn |
| Mar 31, 2024 | 30.57 Mn |
| Dec 31, 2023 | 31.51 Mn |
| Sep 30, 2023 | 33.05 Mn |
| Jun 30, 2023 | 34.08 Mn |
| Mar 31, 2023 | 34.87 Mn |
| Dec 31, 2022 | 35.11 Mn |
| Sep 30, 2022 | 46.43 Mn |
| Jun 30, 2022 | 47.60 Mn |
| Mar 31, 2022 | 48.96 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Sep 30, 2021 | 49.65 Mn |
TherapeuticsMD Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();